Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated Plasmodium falciparum infection

J Travel Med. 2023 Dec 28;30(8):taad159. doi: 10.1093/jtm/taad159.

Authors

Eric S Halsey¹, Mateusz M Plucinski^{2

3}

Affiliations

¹ Division of Global Migration Health, Travelers' Health Branch, Centers for Disease Control and Prevention, Atlanta 30329-4027, USA.
² Division of Parasitic Diseases and Malaria, Malaria Branch, Centers for Disease Control and Prevention, Atlanta 30329-4027, USA.
³ U.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Atlanta 30329-4027, USA.

No abstract available

Keywords: Malaria; artemether-lumefantrine; artemisinin-based combination therapy; resistance; traveller.

Publication types

Comment

MeSH terms

Antimalarials* / therapeutic use
Artemether / therapeutic use
Artemether, Lumefantrine Drug Combination / therapeutic use
Drug Combinations
Ethanolamines / therapeutic use
Fluorenes / therapeutic use
Humans
Lumefantrine / therapeutic use
Malaria, Falciparum* / drug therapy
Plasmodium falciparum
Treatment Failure

Substances

Antimalarials
Artemether
Artemether, Lumefantrine Drug Combination
Lumefantrine
Drug Combinations
Ethanolamines
Fluorenes

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States